Science Explorer Interactive view Map
Company · Beaconsfield · United Kingdom

BioPharm (United Kingdom)

biopharmservices.comROR OpenAlex
Research works
62
▼ 8% vs 2013–17
Citations
943
15.1 per fractional work
Top-10% rate
24.5%
record average 16.5%
Open access
41%
world 28%

Not ranked overall: BioPharm (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.61× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.57× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.59× its world share, 0 worksImmunology and Micro…Neuroscience: 1.76× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.74× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 2.07× its world share, 0 worksChemical EngineeringChemistry: 5.20× its world share, 1 worksChemistryComputer Science: 0.31× its world share, 0 worksComputer ScienceEngineering: 0.23× its world share, 0 worksEngineeringMaterials Science: 1.09× its world share, 0 worksMaterials ScienceMathematics: 0.82× its world share, 0 worksMathematicsHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.55× its world share, 6 worksMedicineBusiness, Management and Accounting: 0.90× its world share, 0 worksBusiness, Management…Decision Sciences: 0.06× its world share, 0 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 5.2×. Every wedge is a field page.

Which keywords describe research at BioPharm (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Pharmaceutical Industry, Glycosylation, Drug Development Costs, Generic Drugs and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life8▲ 9.0×5 topics
  2. Cost-effectiveness Analysis6▲ 132×1 topic
  3. Health Utility Measures6▲ 132×1 topic
  4. Pharmaceutical Industry5▲ 189×2 topics
  5. Glycosylation5▲ 33×3 topics
  6. Drug Development Costs4▲ 258×1 topic
  7. Generic Drugs4▲ 258×1 topic
  8. Monoclonal Antibodies4▲ 43×3 topics
  9. Epidemiology4▲ 1.46×20 topics
  10. Therapeutic Antibodies4▲ 43×2 topics
  11. Cell Culture3▲ 39×3 topics
  12. Inflammation3▲ 1.80×14 topics
  13. Clinical Trials2▲ 6.6×5 topics
  14. Drug Development2▲ 26×3 topics
  15. Monoclonal Antibody2▲ 54×2 topics
  16. Primary Care2▲ 7.9×5 topics
  17. Antibody Engineering2▲ 32×1 topic
  18. Biopharmaceuticals2▲ 46×3 topics
  19. Fc Receptors2▲ 32×1 topic
  20. Innovation2▲ 3.5×4 topics
  21. Mammalian Cells2▲ 83×1 topic
  22. Recombinant Protein2▲ 83×1 topic
  23. TGF-ß2▲ 19×4 topics
  24. Immunogenicity2▲ 59×2 topics
  25. Fibrosis2▲ 14×4 topics
  26. Management2▲ 3.3×6 topics
  27. Protein Aggregation2▲ 31×2 topics
  28. Recombinant Proteins2▲ 47×2 topics
  29. Chromatography2▲ 82×1 topic
  30. Refolding2▲ 82×1 topic
  31. Stability2▲ 12×2 topics
  32. Off-Label Drug Use1▲ 61×1 topic
  33. Pediatric Pharmacokinetics1▲ 61×1 topic
  34. Cancer Immunotherapy1▲ 15×3 topics
  35. Idiopathic Pulmonary Fibrosis1▲ 54×1 topic
  36. Interstitial Lung Disease1▲ 38×1 topic
  37. Regenerative Medicine1▲ 8.0×4 topics
  38. COVID-19 Vaccine1▲ 41×1 topic
  39. Respiratory1▲ 16×2 topics
  40. Vaccine Hesitancy1▲ 46×1 topic

Which research topics does BioPharm (United Kingdom) publish most on?

By volume in 2022–2025: Pharmaceutical studies and practices, Dialysis and Renal Disease Management, Cancer Genomics and Diagnostics and Colorectal Cancer Screening and Detection.

Pharmaceutical studies a…0Pharmaceutical studies and practices: 0 fractional worksDialysis and Renal Disea…0Dialysis and Renal Disease Management: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksColorectal Cancer Screening and Detection: 0 fractional worksGlobal Cancer Incidence and Screening: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksEndometriosis Research and Treatment: 0 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksCAR-T cell therapy research: 0 fractional worksInfluenza Virus Research Studies: 0 fractional works
Pediatrics, Perinatology and Child HealthNephrologyCancer ResearchOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  2. 2 Dialysis and Renal Disease Management Nephrology 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 Colorectal Cancer Screening and Detection Oncology 0 works
  5. 5 Global Cancer Incidence and Screening Oncology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Endometriosis Research and Treatment Reproductive Medicine 0 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  9. 9 CAR-T cell therapy research Oncology 0 works
  10. 10 Influenza Virus Research Studies Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.8%not open59.2%

World: 28% of research is openly available.

with international co-authors35.9%domestic only64.1%

World: 19% is written across borders.

How has BioPharm (United Kingdom)'s research output changed?

Output in 2018–2022 was 8% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Beaconsfield

All research institutions in Beaconsfield

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.